We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $217M invested in Standard BioTools in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 81 → 84 (+3)

5% more call options, than puts

Call options by funds: $238K | Put options by funds: $227K

0.42% more ownership

Funds ownership: 95.01% → 95.42% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less capital invested

Capital invested by funds: $217M → $217M (-$852K)

Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
38
Reduced
18
Closed
9
Calls
$238K
Puts
$227K
Net Calls
+$11K
Net Calls Change
+$28K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$3.6M
2
Millennium Management
Millennium Management
New York
+$2.45M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.02M
4
SSA
Schonfeld Strategic Advisors
New York
+$982K
5
Renaissance Technologies
Renaissance Technologies
New York
+$965K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.65M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$1.47M
3
WA
Wasatch Advisors
Utah
-$1.3M
4
SAM
Silverback Asset Management
North Carolina
-$953K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$795K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Perkins Capital Management
Minnesota
$898K +$139K +21,100 +16%
SSA
27
Schonfeld Strategic Advisors
New York
$873K +$982K +149,506 New
Two Sigma Investments
28
Two Sigma Investments
New York
$825K +$162K +24,669 +21%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$804K +$236K +35,941 +35%
IP
30
Intellectus Partners
California
$792K – – –
OAM
31
Oxford Asset Management
United Kingdom
$656K +$538K +81,879 +268%
Deutsche Bank
32
Deutsche Bank
Germany
$604K -$229K -34,942 -25%
TCIM
33
TIAA CREF Investment Management
New York
$502K – – –
EI
34
EAM Investors
California
$459K +$516K +78,554 New
Charles Schwab
35
Charles Schwab
California
$420K – – –
Invesco
36
Invesco
Georgia
$363K +$321K +48,902 +371%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$350K -$7.81K -1,190 -2%
TA
38
Teachers Advisors
New York
$347K -$36.1K -5,504 -8%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$325K +$261K +39,788 +250%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$318K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$253K – – –
Jennison Associates
42
Jennison Associates
New York
$235K +$264K +40,271 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$227K +$82.7K +12,600 +48%
PPA
44
Parametric Portfolio Associates
Washington
$222K +$4.52K +689 +2%
DZ Bank
45
DZ Bank
Germany
$208K +$2.29K +348 New
Nisa Investment Advisors
46
Nisa Investment Advisors
Missouri
$207K +$55.2K +8,400 +36%
PP
47
PDT Partners
New York
$206K +$31.5K +4,802 +16%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$195K +$36.1K +5,505 +20%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$190K -$2.94K -447 -1%
Wells Fargo
50
Wells Fargo
California
$169K +$74.7K +11,377 +65%
1
2
3 4

LAB Hedge Fund Activity: Q1 2018 in Review

84 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2018, worth a combined $217M — down 0.39% from $217M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LAB positions and 9 closed out — a net gain of 3 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $3.6M. The largest seller was Adage Capital Partners, cutting an estimated $7.65M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q1 2018, up from 81 in Q4 2017.
  • Funds reported $217M of Standard BioTools stock for Q1 2018, down 0.39% quarter-over-quarter.
  • 12 funds opened new Standard BioTools positions in Q1 2018 and 9 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q1 2018 was Levin Capital Strategies, an estimated $3.6M added.
  • The largest Standard BioTools seller in Q1 2018 was Adage Capital Partners, an estimated $7.65M sold.

Based on aggregated 13F filings for Q1 2018.